weight loss drug prescriptions semaglutide tirzepatide q3 2024 data Association between socioeconomic factors and use for loss: a population-based cross-sectional study in Denmark Shortages improve for Lilly's GLP-1

Keep the vials in their original packaging to protect them from light exposure, which accelerates peptide degradation

Some evidence suggests that weight loss itself affects thyroid function

Food and Drug Administration (FDA) has approved the Wegovy pill, marking a historic milestone as the first oral GLP-1 medication for weight loss

A study indicated that tirzepatide ameliorates high glucose-induced damage to nerve cells (Lin et al., 2023)

In the setting of SARS-CoV-2, COVID-19 and oxidative stress, patients with comorbidities may have altered levels of glutamate-cysteine ligase and GSH synthetase, the enzymes participating in GSH synthesis